Evaluation of Dosimetry Formalisms in Intraoperative Radiation Therapy of Glioblastoma

Purpose: The intraoperative radiotherapy in newly diagnosed glioblastoma multiforme (INTRAGO) clinical trial assesses sur-vival in patients with glioblastoma treated with intraoperative radiation therapy (IORT) using the INTRABEAM. Treatment plan-ning for INTRABEAM relies on vendor-provided in-water depth dose curves obtained according to the TARGeted Intraoperative radioTherapy (TARGIT) dosimetry protocol. However, recent studies have shown discrepancies between the estimated TARGIT and delivered doses. This work evaluates the effect of the choice of dosimetry formalism on organs at risk (OAR) doses.Methods and Materials: A treatment planning framework for INTRABEAM was developed to retrospectively calculate the IORT dose in 8 INTRAGO patients. These patients received an IORT prescription dose of 20 to 30 Gy in addition to external beam radiation therapy. The IORT dose was obtained using (1) the TARGIT method; (2) the manufacturer's V4.0 method; (3) the CQ method, which uses an ionization chamber Monte Carlo (MC) calculated factor; (4) MC dose-to-water; and (5) MC dose-to-tissue. The IORT dose was converted to 2 Gy fractions equivalent dose. Results: According to the TARGIT method, the OAR dose constraints were respected in all cases. However, the other formal-isms estimated a higher mean dose to OARs and revealed 1 case where the constraint for the brain stem was exceeded. The addition of the external beam radiation therapy and TARGIT IORT doses resulted in 10 cases of OARs exceeding the dose con-straints. The more accurate MC calculation of dose-to-tissue led to the highest dosimetric differences, with 3, 3, 2, and 2 cases (out of 8) exceeding the dose constraint to the brain stem, optic chiasm, optic nerves, and lenses, respectively. Moreover, the mean cumulative dose to brain stem exceeded its constraint of 66 Gy with the MC dose-to-tissue method, which was not evi-dent with the current INTRAGO clinical practice.Conclusions: The current clinical approach of calculating the IORT dose with the TARGIT method may considerably under-estimate doses to nearby OARs. In practice, OAR dose constraints may have been exceeded, as revealed by more accurate methods. (c) 2023 Elsevier Inc. All rights reserved.